Company Quick10K Filing
Accelerate Diagnostics
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-05
10-K 2016-12-31 Filed 2017-02-28
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-08
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-09
10-Q 2015-09-30 Filed 2015-11-02
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-26
10-Q 2014-09-30 Filed 2014-11-04
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-03-07
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-20 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-10
10-Q 2012-10-31 Filed 2012-12-14
10-K 2012-07-31 Filed 2012-10-26
10-Q 2012-04-30 Filed 2012-06-13
10-Q 2012-01-31 Filed 2012-03-15
10-Q 2011-10-31 Filed 2011-12-14
10-K 2011-07-31 Filed 2011-10-27
10-Q 2011-04-30 Filed 2011-06-14
10-Q 2011-01-31 Filed 2011-03-16
10-Q 2010-10-31 Filed 2010-12-14
10-K 2010-07-31 Filed 2010-09-16
10-Q 2010-04-30 Filed 2010-06-14
10-Q 2010-01-31 Filed 2010-03-17
8-K 2020-08-18 Other Events, Exhibits
8-K 2020-06-29 Officers
8-K 2020-06-22 Officers
8-K 2020-05-08
8-K 2020-05-04
8-K 2020-04-15
8-K 2020-04-14
8-K 2020-03-24
8-K 2020-02-27
8-K 2020-01-31
8-K 2020-01-13
8-K 2019-12-20
8-K 2019-12-01
8-K 2019-11-07
8-K 2019-10-31
8-K 2019-08-20
8-K 2019-08-02
8-K 2019-05-10
8-K 2019-05-09
8-K 2019-02-19
8-K 2019-01-06
8-K 2018-12-21
8-K 2018-12-04
8-K 2018-11-06
8-K 2018-09-25
8-K 2018-08-06
8-K 2018-05-09
8-K 2018-05-03
8-K 2018-03-22
8-K 2018-02-15
8-K 2018-01-10

Accelerate Diagnostics Financials

AXDX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Illumina (ILMN) 44,722 69% 35.1 14% 7,089 2,650 3,458 2,395 973 1,255 44,038
Agilent Technologies (A) 24,292 54% 18.0 9% 9,452 4,704 5,163 2,805 877 1,368 24,690
Mettler Toledo (MTD) 17,554 58% 26.5 21% 2,636 2,198 2,983 1,720 550 700 18,558
Waters (WAT) 15,473 18% 31.8 15% 2,561 2,446 2,405 428 392 513 16,324
Bio-Rad Laboratories (BIO) 10,341 55% 12.0 5% 7,177 2,046 2,304 1,259 377 850 10,215
PerkinElmer (PKI) 9,500 48% 25.3 4% 6,489 3,782 2,835 1,374 234 449 11,362
Bruker (BRKR) 6,836 48% 23.2 9% 2,352 1,507 2,026 972 207 305 7,055
Coherent (COHR) 3,296 34% 37.6 3% 2,083 798 1,431 486 54 79 2,977
Accelerate Diagnostics (AXDX) 1,034 45% -15.4 -58% 147 137 8 3 -85 -72 1,112
Pacific Biosciences of California (PACB) 862 33% -7.4 -79% 146 95 82 27 -115 -113 840
Fluidigm (FLDM) 852 40% -16.2 -19% 269 107 117 46 -52 -51 824
Quanterix (QTRX) 607 39% -12.8 -22% 176 39 52 20 -39 -39 501
EyePoint Pharmaceuticals (EYPT) 194 67% -2.9 -101% 79 63 12 8 -80 -72 209
Harvard Bioscience (HBIO) 130 55% 33.8 -1% 163 86 119 66 -2 5 175
HTG Molecular Diagnostics (HTGM) 36 48% 0.2 -29% 51 23 14 7 -15 -13 -2
Precipio (PRPO) 20 4% -2.2 -42% 23 7 6 0 -9 -9 19
Astrotech (ASTC) 11 17% -1.4 -144% 5 4 0 0 -7 -7 10
Bionano Genomics (BNGO) 7 29% 0.1 -81% 19 27 11 3 -16 -13 -1
Aethlon Medical (AEMD) 0 0% 0.1 -579% 1 1 0 0 -7 -7 -0

Balance Sheet ($MM)2011-10-312012-01-312012-04-302012-07-312012-10-312013-03-312013-06-202013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash110141329273330266558544735251217238291910633429127676266758793
Accounts Receivable
Inventory0000014678101198988
PP&E000001111233456688999911111113131616161719
Assets66617163129464341827570635345139126111978374148136126213218201185172159147
Accounts Payable00000000111122223322112123221322
Long-Term Debt0000000099172172172
Liabilities2222212123334545665555667107123123128129133137
Stockholders' Equity54415133028454239797266594940133120105917869142130119106957757432610
Income Statement ($MM)2011-10-312012-01-312012-04-302012-07-312012-10-312013-03-312013-06-202013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000000000000000011121212222
Cost of Revenue00010111111
Gross Profit11110111111
R&D0000124344566676678854666768766
SG&A000211111243335467991011111211141512131313
Tax10000000000-0
Net Income-0-0-0-4-2-3-4-4-5-5-8-9-9-9-12-11-13-15-18-17-16-14-16-17-16-21-23-22-22-22-20-20
Cash Flow ($MM)2011-10-312012-01-312012-04-302012-07-312012-10-312013-03-312013-06-202013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-0-0-0-0-1-2-3-3-3-4-4-6-5-7-9-9-10-13-15-13-13-15-13-14-13-16-19-18-20-14-17
Cash Investing-0-0-0-0-0-1-1-11-1-1-2-101-3-11-34-21334-20-15512-6312252521
Cash Financing02020200145-00000104-111128512102231412